29

Articles

27

Sources

21%

Analysis & opinion

The reporting

A neutral summary of the key facts most outlets agree on, drawn from reporting across the political spectrum.

President Donald Trump announced Wednesday he will nominate Dr. Heidi Overton, a White House domestic policy adviser, to serve as commissioner of the Food and Drug Administration. If confirmed by the Senate, Overton would take over an agency that has faced leadership turnover, layoffs and political pressure, following former commissioner Marty Makary’s resignation in May. Overton is a physician and deputy director of the White House Domestic Policy Council who has helped shape Trump’s second-term health agenda. Senate Health Committee Chair Bill Cassidy said her role in a recent vaccine order raised “strong concerns” and was “almost disqualifying.”

Analysis & opinion

The arguments that emerged from this coverage — built only from the analysis and opinion pieces, never from straight reporting. Each dot is one article, placed by its outlet's bias — left to right. How to read our graphics →
angles sorted left-argued → right-argued
·

Unfit FDA PickLeans Left

Heidi Overton’s nomination to lead the FDA is alarming because her anti-abortion views and vaccine misinformation ties conflict with the agency’s public health mission. She is portrayed as anti-science and therefore unsuitable for the role.

Common Dreams
The Guardian

Get tomorrow's edition

Every side, every morning — free in your inbox.

More of today's stories

all of today's stories →